Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Criteo Expands Regional Reach Through New Reseller Partnership with Tyroo

businesswire.com
CRTO

AEVEX Selected for Up to $92.2M SkyRange Contract Supporting Department of War Hypersonic Testing

businesswire.com
AVEX

Hyperscale Data Holds Approximately $51 Million of Bitcoin, Cash, and Restricted Cash as of September 13, 2026; Bitcoin, Cash, and Restricted Cash Represents Approximately 136% of Market Capitalization of Common Stock

prnewswire.com
GPUS

New Research: Over Half of Adults Worry about a Disaster, But Cost Keeps them from Preparing

globenewswire.com
VZ

ACAMS Welcomes Jen Calvery, HSBC Financial Crime Risk and Compliance Head, to its Board of Directors

businesswire.com
HSBC GOOGL BAC

Q4 FY26 and Full FY26 Results: LuxExperience with strong +7.6% Net Sales growth ex-FX and improved Adjusted EBITDA profitability in Q4 FY26 now set for accelerated Top- and Bottom-Line growth in FY27

businesswire.com
LUXE

Quest Software Takes Aim at Rogue AI Agents as Identity Security Threats Drive 90% of Cyber Incidents

prnewswire.com
MSFT

Managing Service Providers Including CRO and CMOs Oversight to Comply with ICH GCP R3 Scheduled for October 14–15, 2027

globenewswire.com
GSK

Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds

accessnewswire.com
SNN

CD137-Targeted Therapy Market Set for Growth as Novel Therapeutic Approaches, Advanced Technology Platforms and Expanding Clinical Trials Unlock New Opportunities Through 2026

globenewswire.com
BNTX
View all news →